# The Role of mRNA-based Urine Test (Xpert Bladder Cancer Monitor) in Predicting the Need for Second Look Biopsy After Transurethral Resection of Non Muscle-invasive Bladder Tumor.

> **NCT04603612** · NA · COMPLETED · sponsor: **Mansoura University** · enrollment: 254 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **PROCEDURE:** Primary TURBT

## Key facts

- **NCT ID:** NCT04603612
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-01
- **Primary completion:** 2020-09-01
- **Final completion:** 2020-10-01
- **Target enrollment:** 254 (ACTUAL)
- **Last updated:** 2020-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04603612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04603612, "The Role of mRNA-based Urine Test (Xpert Bladder Cancer Monitor) in Predicting the Need for Second Look Biopsy After Transurethral Resection of Non Muscle-invasive Bladder Tumor.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04603612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*